Brief: Hikma And Richter Announce FDA Submission Acceptance For Denosumab Biosimilar Products
Dec 12 (Reuters) - Hikma Pharmaceuticals PLC HIK.L :
* HIKMA AND RICHTER ANNOUNCE FDA SUBMISSION ACCEPTANCE FOR
DENOSUMAB BIOSIMILAR PRODUCTS
Source text: ID:
Further company coverage: HIK.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Richter Gedeon Vegyeszeti Gyar Nyrt
See all newsAI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Hungary's Richter Says 2026 Guidance Fully Reiterated High-Single-Digit Growth In Revenues And Clean EBIT (At Constant Exchange Rates)
Brief: Hungary's Richter says European Commission granted approval for Tuyory, its biosimilar to Tocilizumab